UK markets open in 6 hours 47 minutes

Ono Pharmaceutical Co., Ltd. (OPHLY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
4.9650+0.0050 (+0.10%)
At close: 03:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.07B
Enterprise value 6.25B
Trailing P/E 8.78
Forward P/E 13.55
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.25
Price/book (mrq)1.39
Enterprise value/revenue 0.01
Enterprise value/EBITDA 0.03

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 3-26.53%
S&P500 52-week change 322.38%
52-week high 36.8000
52-week low 34.7100
50-day moving average 35.2684
200-day moving average 35.8402

Share statistics

Avg vol (3-month) 3120.8k
Avg vol (10-day) 3142.39k
Shares outstanding 51.41B
Implied shares outstanding 61.42B
Float 8458.25M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.18
Forward annual dividend yield 43.56%
Trailing annual dividend rate 3110.00
Trailing annual dividend yield 32,217.74%
5-year average dividend yield 42.12
Payout ratio 428.38%
Dividend date 317 Dec 2019
Ex-dividend date 428 Sept 2023
Last split factor 23:1
Last split date 304 Apr 2016

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 25.62%
Operating margin (ttm)36.28%

Management effectiveness

Return on assets (ttm)12.49%
Return on equity (ttm)16.82%

Income statement

Revenue (ttm)498.07B
Revenue per share (ttm)342.68
Quarterly revenue growth (yoy)7.30%
Gross profit (ttm)N/A
EBITDA 190.01B
Net income avi to common (ttm)127.61B
Diluted EPS (ttm)0.5700
Quarterly earnings growth (yoy)8.20%

Balance sheet

Total cash (mrq)135.56B
Total cash per share (mrq)285.53
Total debt (mrq)8.59B
Total debt/equity (mrq)1.09%
Current ratio (mrq)3.95
Book value per share (mrq)1,652.77

Cash flow statement

Operating cash flow (ttm)106.04B
Levered free cash flow (ttm)76.67B